Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Irinotecan 6S 1 (combination) 4Oxaliplatin 3palbociclib 2durvalumab 2Tamoxifen 2Radiation 2Erlotinib Hydrochloride 2Cetuximab 2Capecitabine 2tremelimumab 1trametinib 1titanium silicide 1sintilimab 1olaparib 1nilotinib 1glasdegib 1genexol-PM 1futibatinib 1dabrafenib 1ceritinib 1capmatinib 1anlotinib 1Temozolomide 1Talc 1Surgical Procedures, Operative 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm Metastasis × genexol-PM × Clear all
NCT01169870 2012-01-04

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

National Cancer Center, Korea

Phase 2 Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡